Dr. Carlo Roberto Bernardino, MD

Dr. Bernardino practices at Vantage Eye Center - Salinas in Salinas, California.

Dr. Bernardino's NPI, 1770549412, was assigned on April 21, 2006. Dr. Bernardino graduated from Sidney Kimmel Medical College in 1997. Dr. Bernardino holds California license C54238.

Dr. Bernardino's primary practice is Vantage Eye Center - Salinas, at 622 Abbott Street, Suite A, Salinas, CA 93901. The practice phone is (831) 771-3999.

Dr. Bernardino's primary practice is Vantage Eye Center - Salinas in Salinas, California. Dr. Bernardino is also affiliated with Salinas Valley Health Medical Center. Dmand AI also links Dr. Bernardino to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernardino practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Bernardino's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Bernardino is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bernardino's licenses on file in 6 states: California, Florida, Connecticut, Georgia, Pennsylvania and Delaware.

Dmand AI lists cataract, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma, inflammation of iris and scleritis among the conditions Dr. Bernardino treats.

CMS data shows 4,721 Medicare services from Dr. Bernardino across 20 procedure codes in 2024, for 936 Medicare patients. Medicare paid $313,585 for them.

CMS counts 936 Medicare patients who saw Dr. Bernardino in 2024. The largest group is 65 to 74, with 398 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bernardino's median patient age at 65, with 65% women.

In 2024, Dr. Bernardino wrote 1,012 Medicare Part D claims for 639 patients. 72% of them were for generic drugs. CMS names the drug for 916 of them, across 11 drugs with 11 or more claims each, at $75,136 in total drug cost. In 2023, CMS named 885 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Bernardino for performance year 2024, reported as part of a group. Dr. Bernardino accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Bernardino, published from 2008 to 2016. The most frequent topics are Tomography, X-Ray Computed, Hydrogel, Polyethylene Glycol Dimethacrylate and Orbital Diseases. Dr. Bernardino has published most often in Ophthalmology. Dr. Bernardino's most frequent co-authors are Peter A. Rubin, MD, Marlon Maus, MD, DRPH and Donald J. D'Amico, MD.

CMS Open Payments shows 14 general payments to Dr. Bernardino from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $147.

Dmand AI lists 17 awards for Dr. Bernardino, most recently America's Top Doctors in 2014.

Dr. Bernardino graduated from Sidney Kimmel Medical College in 1997. Dr. Bernardino is a member of AAO and ACS.

Dr. Bernardino is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.